SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-041847
Filing Date
2018-06-22
Accepted
2018-06-22 17:28:21
Documents
3
Period of Report
2018-06-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-15759_28k.htm 8-K 30764
2 EX-1.1 a18-15759_2ex1d1.htm EX-1.1 255629
3 EX-5.1 a18-15759_2ex5d1.htm EX-5.1 15557
  Complete submission text file 0001104659-18-041847.txt   303233
Mailing Address 20-22 BEDFORD ROW LONDON X0 WC1R 4JS
Business Address 20-22 BEDFORD ROW LONDON X0 WC1R 4JS 441-295-5950
Axovant Sciences Ltd. (Filer) CIK: 0001636050 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-37418 | Film No.: 18915382
SIC: 2834 Pharmaceutical Preparations